We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Hematology Analyzers Contribute to Differentiating Febrile Illnesses

By LabMedica International staff writers
Posted on 25 Nov 2015
Distinguishing Dengue virus infection from other febrile thrombocytopenic illnesses such as leptospirosis or enteric fever is important but difficult, due to the unavailability of reliable diagnostic tests.

In recent years, rapid diagnostic tests have been developed for dengue, leptospirosis, and enteric fever; however, these tests suffer from a limited sensitivity in highly endemic regions, and apart from these microbiological tests, a complete blood count is also often requested in these patients.

Scientists at the University of Padjadjaran (Bandung, Indonesia) and their colleagues used fluorescence flow cytometry to quantitate new parameters including cells in the atypical lymphocyte area (AL), high-fluorescent lymphocyte counts (HFLC), immature granulocytes (IG), and immature platelets (IPF). More...
They compared hematocytometry performed by a hematology analyzer in 93 adults with dengue, 11 with leptospirosis, and 6 with enteric fever infection, and in 28 healthy controls.

Hemocytometry was performed on venous blood collected in Ethylenediaminetetraacetic acid (EDTA) vacutainers and analyzed by the Sysmex XE-5000 automated hematology analyzer (Sysmex Corporation; Kobe, Japan). In patients suspected for dengue, hemocytometry was repeated in the critical and recovery phase of the infection, defined as the period within 48 hours after defervescence before platelet counts started to rise and as the period in which platelet counts started rising again, respectively. In patients in whom a clinical suspicion for one or more of these diseases existed, blood was collected at admission for blood cultures for the diagnosis of enteric fever, serology, and rapid testing for leptospirosis and/or molecular diagnostics and serology for dengue.

The total lymphocyte counts between patients with dengue, leptospirosis, and enteric fever showed significant overlap. However, in the patients with dengue, a high percentage of AL (%AL) and HFLC (%HFLC) were present, while this was not the case for leptospirosis and enteric fever. These parameters did not correlate with the severity of dengue infection. Patients with leptospirosis had a significantly higher absolute IG count (a-IG) and percentage (%IG) than patients with enteric fever or with dengue infection. The a-IG and %IG values in the latter groups were similar to the values in the control group. The highest %IPF was found in the patients with dengue, who also had the lowest platelet counts. Low %AL, %HFLC, and %IG supported a diagnosis of enteric fever.

The authors concluded that cells in the atypical lymphocyte flagging area, the high fluorescent lymphocyte count, immature platelets, and immature granulocytes are new hematological parameters that may help to differentiate between common causes of febrile illnesses with thrombocytopenia in dengue endemic areas. The study was published online on September 3, 2015, in the International Journal of Laboratory Hematology.

Related Links:

University of Padjadjaran
Sysmex Corporation 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.